Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

Related Articles by Review for PubMed (Select 9016263)

1.

Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.

Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB.

Am J Psychiatry. 1997 Feb;154(2):165-72.

PMID:
9016263
2.

Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.

McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB, et al.

CMAJ. 1986 Mar 15;134(6):597-607. Review.

3.

[Awareness of deficits and anosognosia in Alzheimer's disease].

Antoine C, Antoine P, Guermonprez P, Frigard B.

Encephale. 2004 Nov-Dec;30(6):570-7. Review. French.

PMID:
15738860
4.

Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.

Herholz K.

Expert Rev Neurother. 2010 Nov;10(11):1667-73. doi: 10.1586/ern.10.136. Review.

PMID:
20977325
5.

PET studies in dementia.

Herholz K.

Ann Nucl Med. 2003 Apr;17(2):79-89. Review.

PMID:
12790355
6.

NIH Conference. Alzheimer's disease and Down's syndrome: new insights.

Cutler NR, Heston LL, Davies P, Haxby JV, Schapiro MB.

Ann Intern Med. 1985 Oct;103(4):566-78. Review.

PMID:
2864010
7.

The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease.

Pietrini P, Alexander GE, Furey ML, Hampel H, Guazzelli M.

Int J Psychophysiol. 2000 Jul;37(1):87-98. Review.

PMID:
10828377
8.

Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.

Mielke R, Heiss WD.

J Neural Transm Suppl. 1998;53:237-50. Review.

PMID:
9700661
9.

Abnormalities of regional brain metabolism in Alzheimer's disease and their relation to functional impairment.

Haxby JV, Rapoport SI.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):427-38. Review.

PMID:
3541045
10.

PET studies and cholinergic therapy in Alzheimer's disease.

Nordberg A.

Rev Neurol (Paris). 1999;155 Suppl 4:S53-63. Review.

PMID:
10637939
11.

Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.

Weinstein HC, Scheltens P, Hijdra A, van Royen EA.

Clin Neurol Neurosurg. 1993 Jun;95(2):81-91. Review. No abstract available.

PMID:
8344019
12.

Functional brain imaging and Alzheimer-type dementia.

Guze BH, Hoffman JM, Baxter LR Jr, Mazziotta JC, Phelps ME.

Alzheimer Dis Assoc Disord. 1991 Winter;5(4):215-30. Review.

PMID:
1781964
13.

Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomography.

Rapoport SI, Horwitz B, Grady CL, Haxby JV, DeCarli C, Schapiro MB.

Adv Exp Med Biol. 1991;291:231-48. Review.

PMID:
1927686
14.

Positron computed tomography for studies of myocardial and cerebral function.

Phelps ME, Schelbert HR, Mazziotta JC.

Ann Intern Med. 1983 Mar;98(3):339-59. Review.

PMID:
6219602
15.

Positron emission tomography and the possible origins of cytopathology in Alzheimer's disease.

McGeer PL, McGeer EG, Kamo H, Wong K.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):501-18. Review.

PMID:
3541048
16.

Alzheimer's disease and intelligence.

Yeo RA, Arden R, Jung RE.

Curr Alzheimer Res. 2011 Jun;8(4):345-53. Review.

PMID:
21222590
17.

Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease.

Chandrasekaran K, Hatanpää K, Brady DR, Rapoport SI.

Exp Neurol. 1996 Nov;142(1):80-8. Review.

PMID:
8912900
18.

Brain imaging in Alzheimer's disease.

McGeer PL.

Br Med Bull. 1986 Jan;42(1):24-8. Review. No abstract available.

PMID:
3513888
19.

Cerebral metabolic changes in Alzheimer's disease: neurobehavioral patterns.

Blesa R, Mohr E, Miletich RS, Hildebrand K, Sampson M, Chase TN.

Dementia. 1996 Sep-Oct;7(5):239-45. Review.

PMID:
8872413
20.

Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.

Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG.

Neuropsychol Rev. 1996 Jun;6(2):61-79. Review.

PMID:
8976498
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk